Laila Agrawal, MD IF
@lailaagrawalmd.bsky.social
Medical oncologist @ Norton Cancer Institute, Louisville KY
Breast cancer specialist | Sexual health after cancer | Community onc | Opinions my own
Breast cancer specialist | Sexual health after cancer | Community onc | Opinions my own
Part 2⃣Studies of HRT in breast cancer coming in 🔥🔥🔥@ASCO #ASCO25!!
Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.
Fewer hot flashes 🥵, more dizziness 😵💫
Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.
Fewer hot flashes 🥵, more dizziness 😵💫
June 1, 2025 at 3:05 PM
Part 2⃣Studies of HRT in breast cancer coming in 🔥🔥🔥@ASCO #ASCO25!!
Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.
Fewer hot flashes 🥵, more dizziness 😵💫
Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.
Fewer hot flashes 🥵, more dizziness 😵💫
Studies of HRT in breast cancer coming in 🔥🔥🔥 #ASCO25!!@ascocancer.bsky.social
🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.
Sets the stage for more studies of CE/BZA in #bcsm
🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.
Sets the stage for more studies of CE/BZA in #bcsm
June 1, 2025 at 3:03 PM
Studies of HRT in breast cancer coming in 🔥🔥🔥 #ASCO25!!@ascocancer.bsky.social
🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.
Sets the stage for more studies of CE/BZA in #bcsm
🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.
Sets the stage for more studies of CE/BZA in #bcsm
Don’t miss our session on sexual health at #ASCO25 with @lizoriordan.bsky.social and Lawrence Jenkins.
May 24, 2025 at 12:41 PM
Don’t miss our session on sexual health at #ASCO25 with @lizoriordan.bsky.social and Lawrence Jenkins.